<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">21253590</PMID>
        <DateCompleted>
            <Year>2011</Year>
            <Month>08</Month>
            <Day>02</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>6</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2011</Year>
                        <Month>Jan</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS One</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Tissue-specific analysis of glycogen synthase kinase-3α (GSK-3α) in glucose metabolism: effect of strain variation.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e15845</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0015845</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Over-activity and elevated expression of glycogen synthase kinase-3 (GSK-3) has been implicated in the etiology of insulin resistance and Type 2 diabetes. Administration of specific GSK-3 inhibitors to diabetic or obese rodent models improves glycaemic control and insulin sensitivity. However, due to the indiscriminatory nature of these inhibitors, the relative contribution of the two isoforms of GSK-3 (GSK-3α and GSK-3β) is not known. Recently, we demonstrated that an out-bred strain of mice (ICR) lacking expression of GSK-3α in all tissues displayed improved insulin sensitivity and enhanced hepatic glucose metabolism. We also found that muscle (but not liver) inactivation of GSK-3β conferred insulin and glucose sensitization in an in-bred strain of mice (C57BL/6).</AbstractText>
                <AbstractText Label="METHODOLOGY/PRINCIPAL FINDINGS" NlmCategory="RESULTS">Here, we have employed tissue-specific deletion of GSK-3α, to examine the relative contribution of two insulin-sensitive tissues, muscle and liver, towards the insulin sensitization phenotype originally observed in the global GSK-3α KO animals. We found that mice in which GSK-3α has been inactivated in either skeletal-muscle or liver displayed no differences in glucose tolerance or insulin sensitivity compared to wild type littermates. Given the strain differences in our original analyses, we examined the insulin and glucose sensitivity of global GSK-3α KO animals bred onto a C57BL/6 background. These animals also revealed no significant differences in glucose metabolism/insulin sensitivity compared to their wild type littermates. Furthermore, deletion of hepatic GSK-3α on the out-bred, ICR background failed to reproduce the insulin sensitivity manifested by the global deletion of this isoform.</AbstractText>
                <AbstractText Label="CONCLUSIONS/SIGNIFICANCE" NlmCategory="CONCLUSIONS">From these data we conclude that the improved insulin sensitivity and hepatic glucose homeostasis phenotype observed upon global inactivation of GSK-3α is strain-specific. We surmise that the insulin-sensitization observed in the out-bred strain of mice lacking GSK-3α is mediated by indirect means that do not require intrinsic function of GSK-3α in skeletal muscle and liver tissues.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Patel</LastName>
                    <ForeName>Satish</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Macaulay</LastName>
                    <ForeName>Katrina</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Woodgett</LastName>
                    <ForeName>James R</ForeName>
                    <Initials>JR</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>MOP 74711</GrantID>
                    <Agency>Canadian Institutes of Health Research</Agency>
                    <Country>Canada</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2011</Year>
                <Month>01</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007328">Insulin</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.11.1</RegistryNumber>
                <NameOfSubstance UI="D000071679">Glycogen Synthase Kinase 3 beta</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.11.1</RegistryNumber>
                <NameOfSubstance UI="C000605507">Gsk3b protein, mouse</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.11.26</RegistryNumber>
                <NameOfSubstance UI="D038362">Glycogen Synthase Kinase 3</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.11.26</RegistryNumber>
                <NameOfSubstance UI="C448021">glycogen synthase kinase 3 alpha</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>IY9XDZ35W2</RegistryNumber>
                <NameOfSubstance UI="D005947">Glucose</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D038362" MajorTopicYN="N">Glycogen Synthase Kinase 3</DescriptorName>
                <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
                <QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName>
                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000071679" MajorTopicYN="N">Glycogen Synthase Kinase 3 beta</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009132" MajorTopicYN="N">Muscles</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014018" MajorTopicYN="N">Tissue Distribution</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2010</Year>
                <Month>08</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2010</Year>
                <Month>11</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2011</Year>
                <Month>1</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2011</Year>
                <Month>1</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2011</Year>
                <Month>8</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">21253590</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0015845</ArticleId>
            <ArticleId IdType="pmc">PMC3017066</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Biol Chem. 1999 Jan 1;274(1):305-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9867845</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2005 Apr;115(4):940-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15841180</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genesis. 2000 Feb;26(2):165-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10686620</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2000 Jul 6;406(6791):86-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10894547</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trends Mol Med. 2002 Mar;8(3):126-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11879773</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes. 2002 Jul;51(7):2190-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12086949</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes. 2002 Oct;51(10):2903-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12351425</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2002 Dec;8(12):1376-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12426561</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes. 2003 Mar;52(3):588-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12606497</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2004 Oct;114(7):908-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15467829</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2004 Oct;114(7):917-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15467830</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anal Biochem. 1968 Oct 24;25(1):486-99</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">5704765</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EMBO J. 1990 Aug;9(8):2431-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2164470</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes. 1997 Apr;46(4):541-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9075792</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Metabolism. 1998 Jun;47(6):663-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9627363</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EMBO J. 2005 Apr 20;24(8):1571-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15791206</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Metab. 2005 Jan;1(1):53-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16054044</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pharmacol Exp Ther. 2006 Jan;316(1):17-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16169938</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2006 Jul;116(7):1761-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16823473</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Physiol Endocrinol Metab. 2006 Aug;291(2):E207-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16478771</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dev Cell. 2007 Jun;12(6):957-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17543867</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Metab. 2007 Jun;5(6):438-49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17550779</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Metab. 2007 Oct;6(4):329-37</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17908561</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Biol. 2008 Feb;6(2):e37</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18288891</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Ther Targets. 2008 Oct;12(10):1265-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18781825</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell Biol. 2008 Oct;28(20):6314-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18694957</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2008 Nov;118(11):3609-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18830417</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
